Showing results (1-10 of 7) with videos related to

Sort By:
Pageof 1
Pulmonary Pharmacology & Therapeutics|January 1, 2019
Analysis of the drop-out rate in patients receiving mepolizumab for severe asthma in real lifeCarlo Lombardi, Diego Bagnasco, Cristiano Caruso, et al.
Pulmonary Therapy|June 20, 2020
Physical Functioning in Patients with Chronic Obstructive Pulmonary Disease Treated with Tiotropium/Olodaterol Respimat in Routine Clinical Practice in ItalyMauro Carone, Alfio Pennisi, Mariella D'Amato, et al.
Advances in Therapy|May 27, 2021
The Burden of Short-Acting β<sub>2</sub>-Agonist Use in Asthma: Is There an Italian Case? An Update from SABINA ProgramFabiano Di Marco, Mariella D'Amato, Francesco P Lombardo, et al.
Scientific Reports|March 22, 2021
Clinical and economic consequences of switching from omalizumab to mepolizumab in uncontrolled severe eosinophilic asthmaGiovanna Elisiana Carpagnano, Emanuela Resta, Massimiliano Povero, et al.
Biomedicines|February 24, 2024
Dupilumab Efficacy on Asthma Functional, Inflammatory, and Patient-Reported Outcomes across Different Disease Phenotypes and Severity: A Real-Life PerspectiveMarco Caminati, Matteo Maule, Roberto Benoni, et al.
The Journal of Allergy and Clinical Immunology. in Practice|February 16, 2025
Profiling Blood Hypereosinophilia in Patients on Dupilumab Treatment for Respiratory Conditions: A Real-Life SnapshotMarco Caminati, Matteo Maule, Diego Bagnasco, et al.
The Journal of Allergy and Clinical Immunology. in Practice|August 9, 2023
Severe Asthma Network Italy Definition of Clinical Remission in Severe Asthma: A Delphi ConsensusGiorgio Walter Canonica, Francesco Blasi, Giovanna Elisiana Carpagnano, et al.
Pageof 1